Click for best price
Companion Diagnostics CDx Development Services Market Size, Share 2022
This report contains market size and forecasts of Companion Diagnostics (CDx) Development Services in Global, including the following market information:
Global Companion Diagnostics (CDx) Development Services Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Companion Diagnostics (CDx) Development Services market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Feasibility Studies Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Companion Diagnostics (CDx) Development Services include Geneuity-Clinical Research Services, Interpace Biosciences, Labcorp, Quest Diagnostics, Q? Solutions, ResearchDx, Almac Diagnostic Services, Biocartis and Cerba Research, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Companion Diagnostics (CDx) Development Services companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Companion Diagnostics (CDx) Development Services Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Companion Diagnostics (CDx) Development Services Market Segment Percentages, by Type, 2021 (%)
Feasibility Studies
Assay Development
Analytical Validation
Clinical Validation
Others
Global Companion Diagnostics (CDx) Development Services Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Companion Diagnostics (CDx) Development Services Market Segment Percentages, by Application, 2021 (%)
Infectious Diseases
Neurological Disorders
Global Companion Diagnostics (CDx) Development Services Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Companion Diagnostics (CDx) Development Services Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Companion Diagnostics (CDx) Development Services revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Companion Diagnostics (CDx) Development Services revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Geneuity-Clinical Research Services
Interpace Biosciences
Labcorp
Quest Diagnostics
Q? Solutions
ResearchDx
Almac Diagnostic Services
Biocartis
Cerba Research
Eurofins Scientific
MLM Medical Labs
Qiagen
BGI Genomics
MEDx Translational Medicine
Medical Biological Laboratories (MBL)
Novogene
| Report Attributes |
Report Details |
| Report Title |
Companion Diagnostics (CDx) Development Services Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
102 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Companion Diagnostics (CDx) Development Services Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Companion Diagnostics (CDx) Development Services Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Companion Diagnostics (CDx) Development Services Overall Market Size
2.1 Global Companion Diagnostics (CDx) Development Services Market Size: 2021 VS 2028
2.2 Global Companion Diagnostics (CDx) Development Services Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Companion Diagnostics (CDx) Development Services Players in Global Market
3.2 Top Global Companion Diagnostics (CDx) Development Services Companies Ranked by Revenue
3.3 Global Companion Diagnostics (CDx) Development Services Revenue by Companies
3.4 Top 3 and Top 5 Companion Diagnostics (CDx) Development Services Companies in Global Market, by Revenue in 2021
3.5 Global Companies Companion Diagnostics (CDx) Development Services Product Type
3.6 Tier 1, Tier 2 and Tier 3 Companion Diagnostics (CDx) Development Services Players in Global Market
3.6.1 List of Global Tier 1 Companion Diagnostics (CDx) Development Services Companies
3.6.2 List of Global Tier 2 and Tier 3 Companion Diagnostics (CDx) Development Services Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Companion Diagnostics (CDx) Development Services Market Size Markets, 2021 & 2028
4.1.2 Feasibility Studies
4.1.3 Assay Development
4.1.4 Analytical Validation
4.1.5 Clinical Validation
4.1.6 Others
4.2 By Type - Global Companion Diagnostics (CDx) Development Services Revenue & Forecasts
4.2.1 By Type - Global Companion Diagnostics (CDx) Development Services Revenue, 2017-2022
4.2.2 By Type - Global Companion Diagnostics (CDx) Development Services Revenue, 2023-2028
4.2.3 By Type - Global Companion Diagnostics (CDx) Development Services Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Companion Diagnostics (CDx) Development Services Market Size, 2021 & 2028
5.1.2 Infectious Diseases
5.1.3 Neurological Disorders
5.2 By Application - Global Companion Diagnostics (CDx) Development Services Revenue & Forecasts
5.2.1 By Application - Global Companion Diagnostics (CDx) Development Services Revenue, 2017-2022
5.2.2 By Application - Global Companion Diagnostics (CDx) Development Services Revenue, 2023-2028
5.2.3 By Application - Global Companion Diagnostics (CDx) Development Services Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Companion Diagnostics (CDx) Development Services Market Size, 2021 & 2028
6.2 By Region - Global Companion Diagnostics (CDx) Development Services Revenue & Forecasts
6.2.1 By Region - Global Companion Diagnostics (CDx) Development Services Revenue, 2017-2022
6.2.2 By Region - Global Companion Diagnostics (CDx) Development Services Revenue, 2023-2028
6.2.3 By Region - Global Companion Diagnostics (CDx) Development Services Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Companion Diagnostics (CDx) Development Services Revenue, 2017-2028
6.3.2 US Companion Diagnostics (CDx) Development Services Market Size, 2017-2028
6.3.3 Canada Companion Diagnostics (CDx) Development Services Market Size, 2017-2028
6.3.4 Mexico Companion Diagnostics (CDx) Development Services Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Companion Diagnostics (CDx) Development Services Revenue, 2017-2028
6.4.2 Germany Companion Diagnostics (CDx) Development Services Market Size, 2017-2028
6.4.3 France Companion Diagnostics (CDx) Development Services Market Size, 2017-2028
6.4.4 U.K. Companion Diagnostics (CDx) Development Services Market Size, 2017-2028
6.4.5 Italy Companion Diagnostics (CDx) Development Services Market Size, 2017-2028
6.4.6 Russia Companion Diagnostics (CDx) Development Services Market Size, 2017-2028
6.4.7 Nordic Countries Companion Diagnostics (CDx) Development Services Market Size, 2017-2028
6.4.8 Benelux Companion Diagnostics (CDx) Development Services Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Companion Diagnostics (CDx) Development Services Revenue, 2017-2028
6.5.2 China Companion Diagnostics (CDx) Development Services Market Size, 2017-2028
6.5.3 Japan Companion Diagnostics (CDx) Development Services Market Size, 2017-2028
6.5.4 South Korea Companion Diagnostics (CDx) Development Services Market Size, 2017-2028
6.5.5 Southeast Asia Companion Diagnostics (CDx) Development Services Market Size, 2017-2028
6.5.6 India Companion Diagnostics (CDx) Development Services Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Companion Diagnostics (CDx) Development Services Revenue, 2017-2028
6.6.2 Brazil Companion Diagnostics (CDx) Development Services Market Size, 2017-2028
6.6.3 Argentina Companion Diagnostics (CDx) Development Services Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Companion Diagnostics (CDx) Development Services Revenue, 2017-2028
6.7.2 Turkey Companion Diagnostics (CDx) Development Services Market Size, 2017-2028
6.7.3 Israel Companion Diagnostics (CDx) Development Services Market Size, 2017-2028
6.7.4 Saudi Arabia Companion Diagnostics (CDx) Development Services Market Size, 2017-2028
6.7.5 UAE Companion Diagnostics (CDx) Development Services Market Size, 2017-2028
7 Players Profiles
7.1 Geneuity-Clinical Research Services
7.1.1 Geneuity-Clinical Research Services Corporate Summary
7.1.2 Geneuity-Clinical Research Services Business Overview
7.1.3 Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Major Product Offerings
7.1.4 Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Revenue in Global Market (2017-2022)
7.1.5 Geneuity-Clinical Research Services Key News
7.2 Interpace Biosciences
7.2.1 Interpace Biosciences Corporate Summary
7.2.2 Interpace Biosciences Business Overview
7.2.3 Interpace Biosciences Companion Diagnostics (CDx) Development Services Major Product Offerings
7.2.4 Interpace Biosciences Companion Diagnostics (CDx) Development Services Revenue in Global Market (2017-2022)
7.2.5 Interpace Biosciences Key News
7.3 Labcorp
7.3.1 Labcorp Corporate Summary
7.3.2 Labcorp Business Overview
7.3.3 Labcorp Companion Diagnostics (CDx) Development Services Major Product Offerings
7.3.4 Labcorp Companion Diagnostics (CDx) Development Services Revenue in Global Market (2017-2022)
7.3.5 Labcorp Key News
7.4 Quest Diagnostics
7.4.1 Quest Diagnostics Corporate Summary
7.4.2 Quest Diagnostics Business Overview
7.4.3 Quest Diagnostics Companion Diagnostics (CDx) Development Services Major Product Offerings
7.4.4 Quest Diagnostics Companion Diagnostics (CDx) Development Services Revenue in Global Market (2017-2022)
7.4.5 Quest Diagnostics Key News
7.5 Q? Solutions
7.5.1 Q? Solutions Corporate Summary
7.5.2 Q? Solutions Business Overview
7.5.3 Q? Solutions Companion Diagnostics (CDx) Development Services Major Product Offerings
7.5.4 Q? Solutions Companion Diagnostics (CDx) Development Services Revenue in Global Market (2017-2022)
7.5.5 Q? Solutions Key News
7.6 ResearchDx
7.6.1 ResearchDx Corporate Summary
7.6.2 ResearchDx Business Overview
7.6.3 ResearchDx Companion Diagnostics (CDx) Development Services Major Product Offerings
7.6.4 ResearchDx Companion Diagnostics (CDx) Development Services Revenue in Global Market (2017-2022)
7.6.5 ResearchDx Key News
7.7 Almac Diagnostic Services
7.7.1 Almac Diagnostic Services Corporate Summary
7.7.2 Almac Diagnostic Services Business Overview
7.7.3 Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Major Product Offerings
7.7.4 Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Revenue in Global Market (2017-2022)
7.7.5 Almac Diagnostic Services Key News
7.8 Biocartis
7.8.1 Biocartis Corporate Summary
7.8.2 Biocartis Business Overview
7.8.3 Biocartis Companion Diagnostics (CDx) Development Services Major Product Offerings
7.8.4 Biocartis Companion Diagnostics (CDx) Development Services Revenue in Global Market (2017-2022)
7.8.5 Biocartis Key News
7.9 Cerba Research
7.9.1 Cerba Research Corporate Summary
7.9.2 Cerba Research Business Overview
7.9.3 Cerba Research Companion Diagnostics (CDx) Development Services Major Product Offerings
7.9.4 Cerba Research Companion Diagnostics (CDx) Development Services Revenue in Global Market (2017-2022)
7.9.5 Cerba Research Key News
7.10 Eurofins Scientific
7.10.1 Eurofins Scientific Corporate Summary
7.10.2 Eurofins Scientific Business Overview
7.10.3 Eurofins Scientific Companion Diagnostics (CDx) Development Services Major Product Offerings
7.10.4 Eurofins Scientific Companion Diagnostics (CDx) Development Services Revenue in Global Market (2017-2022)
7.10.5 Eurofins Scientific Key News
7.11 MLM Medical Labs
7.11.1 MLM Medical Labs Corporate Summary
7.11.2 MLM Medical Labs Business Overview
7.11.3 MLM Medical Labs Companion Diagnostics (CDx) Development Services Major Product Offerings
7.11.4 MLM Medical Labs Companion Diagnostics (CDx) Development Services Revenue in Global Market (2017-2022)
7.11.5 MLM Medical Labs Key News
7.12 Qiagen
7.12.1 Qiagen Corporate Summary
7.12.2 Qiagen Business Overview
7.12.3 Qiagen Companion Diagnostics (CDx) Development Services Major Product Offerings
7.12.4 Qiagen Companion Diagnostics (CDx) Development Services Revenue in Global Market (2017-2022)
7.12.5 Qiagen Key News
7.13 BGI Genomics
7.13.1 BGI Genomics Corporate Summary
7.13.2 BGI Genomics Business Overview
7.13.3 BGI Genomics Companion Diagnostics (CDx) Development Services Major Product Offerings
7.13.4 BGI Genomics Companion Diagnostics (CDx) Development Services Revenue in Global Market (2017-2022)
7.13.5 BGI Genomics Key News
7.14 MEDx Translational Medicine
7.14.1 MEDx Translational Medicine Corporate Summary
7.14.2 MEDx Translational Medicine Business Overview
7.14.3 MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Major Product Offerings
7.14.4 MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Revenue in Global Market (2017-2022)
7.14.5 MEDx Translational Medicine Key News
7.15 Medical Biological Laboratories (MBL)
7.15.1 Medical Biological Laboratories (MBL) Corporate Summary
7.15.2 Medical Biological Laboratories (MBL) Business Overview
7.15.3 Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Major Product Offerings
7.15.4 Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Revenue in Global Market (2017-2022)
7.15.5 Medical Biological Laboratories (MBL) Key News
7.16 Novogene
7.16.1 Novogene Corporate Summary
7.16.2 Novogene Business Overview
7.16.3 Novogene Companion Diagnostics (CDx) Development Services Major Product Offerings
7.16.4 Novogene Companion Diagnostics (CDx) Development Services Revenue in Global Market (2017-2022)
7.16.5 Novogene Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Companion Diagnostics (CDx) Development Services Market Opportunities & Trends in Global Market
Table 2. Companion Diagnostics (CDx) Development Services Market Drivers in Global Market
Table 3. Companion Diagnostics (CDx) Development Services Market Restraints in Global Market
Table 4. Key Players of Companion Diagnostics (CDx) Development Services in Global Market
Table 5. Top Companion Diagnostics (CDx) Development Services Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Companion Diagnostics (CDx) Development Services Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Companion Diagnostics (CDx) Development Services Revenue Share by Companies, 2017-2022
Table 8. Global Companies Companion Diagnostics (CDx) Development Services Product Type
Table 9. List of Global Tier 1 Companion Diagnostics (CDx) Development Services Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Companion Diagnostics (CDx) Development Services Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Companion Diagnostics (CDx) Development Services Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Companion Diagnostics (CDx) Development Services Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Companion Diagnostics (CDx) Development Services Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Companion Diagnostics (CDx) Development Services Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Companion Diagnostics (CDx) Development Services Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Companion Diagnostics (CDx) Development Services Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2023-2028
Table 30. Geneuity-Clinical Research Services Corporate Summary
Table 31. Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Product Offerings
Table 32. Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Revenue (US$, Mn), (2017-2022)
Table 33. Interpace Biosciences Corporate Summary
Table 34. Interpace Biosciences Companion Diagnostics (CDx) Development Services Product Offerings
Table 35. Interpace Biosciences Companion Diagnostics (CDx) Development Services Revenue (US$, Mn), (2017-2022)
Table 36. Labcorp Corporate Summary
Table 37. Labcorp Companion Diagnostics (CDx) Development Services Product Offerings
Table 38. Labcorp Companion Diagnostics (CDx) Development Services Revenue (US$, Mn), (2017-2022)
Table 39. Quest Diagnostics Corporate Summary
Table 40. Quest Diagnostics Companion Diagnostics (CDx) Development Services Product Offerings
Table 41. Quest Diagnostics Companion Diagnostics (CDx) Development Services Revenue (US$, Mn), (2017-2022)
Table 42. Q? Solutions Corporate Summary
Table 43. Q? Solutions Companion Diagnostics (CDx) Development Services Product Offerings
Table 44. Q? Solutions Companion Diagnostics (CDx) Development Services Revenue (US$, Mn), (2017-2022)
Table 45. ResearchDx Corporate Summary
Table 46. ResearchDx Companion Diagnostics (CDx) Development Services Product Offerings
Table 47. ResearchDx Companion Diagnostics (CDx) Development Services Revenue (US$, Mn), (2017-2022)
Table 48. Almac Diagnostic Services Corporate Summary
Table 49. Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Product Offerings
Table 50. Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Revenue (US$, Mn), (2017-2022)
Table 51. Biocartis Corporate Summary
Table 52. Biocartis Companion Diagnostics (CDx) Development Services Product Offerings
Table 53. Biocartis Companion Diagnostics (CDx) Development Services Revenue (US$, Mn), (2017-2022)
Table 54. Cerba Research Corporate Summary
Table 55. Cerba Research Companion Diagnostics (CDx) Development Services Product Offerings
Table 56. Cerba Research Companion Diagnostics (CDx) Development Services Revenue (US$, Mn), (2017-2022)
Table 57. Eurofins Scientific Corporate Summary
Table 58. Eurofins Scientific Companion Diagnostics (CDx) Development Services Product Offerings
Table 59. Eurofins Scientific Companion Diagnostics (CDx) Development Services Revenue (US$, Mn), (2017-2022)
Table 60. MLM Medical Labs Corporate Summary
Table 61. MLM Medical Labs Companion Diagnostics (CDx) Development Services Product Offerings
Table 62. MLM Medical Labs Companion Diagnostics (CDx) Development Services Revenue (US$, Mn), (2017-2022)
Table 63. Qiagen Corporate Summary
Table 64. Qiagen Companion Diagnostics (CDx) Development Services Product Offerings
Table 65. Qiagen Companion Diagnostics (CDx) Development Services Revenue (US$, Mn), (2017-2022)
Table 66. BGI Genomics Corporate Summary
Table 67. BGI Genomics Companion Diagnostics (CDx) Development Services Product Offerings
Table 68. BGI Genomics Companion Diagnostics (CDx) Development Services Revenue (US$, Mn), (2017-2022)
Table 69. MEDx Translational Medicine Corporate Summary
Table 70. MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Product Offerings
Table 71. MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Revenue (US$, Mn), (2017-2022)
Table 72. Medical Biological Laboratories (MBL) Corporate Summary
Table 73. Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Product Offerings
Table 74. Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Revenue (US$, Mn), (2017-2022)
Table 75. Novogene Corporate Summary
Table 76. Novogene Companion Diagnostics (CDx) Development Services Product Offerings
Table 77. Novogene Companion Diagnostics (CDx) Development Services Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Companion Diagnostics (CDx) Development Services Segment by Type in 2021
Figure 2. Companion Diagnostics (CDx) Development Services Segment by Application in 2021
Figure 3. Global Companion Diagnostics (CDx) Development Services Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Companion Diagnostics (CDx) Development Services Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Companion Diagnostics (CDx) Development Services Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Companion Diagnostics (CDx) Development Services Revenue in 2021
Figure 8. By Type - Global Companion Diagnostics (CDx) Development Services Revenue Market Share, 2017-2028
Figure 9. By Application - Global Companion Diagnostics (CDx) Development Services Revenue Market Share, 2017-2028
Figure 10. By Region - Global Companion Diagnostics (CDx) Development Services Revenue Market Share, 2017-2028
Figure 11. By Country - North America Companion Diagnostics (CDx) Development Services Revenue Market Share, 2017-2028
Figure 12. US Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Companion Diagnostics (CDx) Development Services Revenue Market Share, 2017-2028
Figure 16. Germany Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2017-2028
Figure 17. France Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Companion Diagnostics (CDx) Development Services Revenue Market Share, 2017-2028
Figure 24. China Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2017-2028
Figure 28. India Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Companion Diagnostics (CDx) Development Services Revenue Market Share, 2017-2028
Figure 30. Brazil Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Companion Diagnostics (CDx) Development Services Revenue Market Share, 2017-2028
Figure 33. Turkey Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Companion Diagnostics (CDx) Development Services Revenue, (US$, Mn), 2017-2028
Figure 37. Geneuity-Clinical Research Services Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Interpace Biosciences Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Labcorp Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Quest Diagnostics Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Q? Solutions Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. ResearchDx Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Almac Diagnostic Services Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Biocartis Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Cerba Research Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Eurofins Scientific Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. MLM Medical Labs Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Qiagen Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. BGI Genomics Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. MEDx Translational Medicine Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Medical Biological Laboratories (MBL) Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Novogene Companion Diagnostics (CDx) Development Services Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
